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Abstract
Background: Pulmonary perfusion is not spatially homogeneously distributed, and its variations could be of
diagnostic value in lung vascular disease. PulmoBind is a ligand of the adrenomedullin receptor densely expressed
in endothelial cells of lung capillaries. The aim of this study was to evaluate spatial distribution of human lung
perfusion by using this novel molecular tracer of the pulmonary vascular endothelium.
Methods: Normal humans (n = 19) enrolled into the PulmoBind phase I trial were studied (Clinicaltrials.gov.
NCT01539889). They were injected with 99mTc-PulmoBind for SPECT imaging. Results were compared with
99mTc-PulmoBind in quadruped mammals (dogs, n = 5). Imaging was performed in the supine position and distribution
of activity was determined as a function of cumulative voxels along the different anatomical planes.
Results: PulmoBind uptake in humans was 58 ± 1 % (mean ± SEM) of the injected dose. Dorsal activity was 18.1 ± 2.
1 % greater than ventral, and caudal activity was 25.7 ± 1.6 % greater than cranial. Lateral activity was only mildly
higher than medial by 7.0 ± 1.0 %. In supine dogs, similar but higher PulmoBind gradients were present: dorsal 28.6 ± 2.
5 %, caudal 34.1 ± 5.0 % and lateral 18.1 ± 2.0 %.
Conclusions: The perfused pulmonary circulation of supine humans, assessed by an adrenomedullin receptor ligand, is
not homogeneously distributed with more prominent distribution in dorsal and caudal regions. It is qualitatively similar
to a supine quadruped mammal confirming the presence of a microcirculatory gravitational perfusion gradient
detectable with this tracer. Future studies are needed to determine if this novel endothelial cell tracer could be used to
detect physiologic and pathologic variations of lung perfusion such as in pulmonary hypertension.
Clinical trial: ClinicalTrial.gov, NCT01539889
Keywords: Pulmonary vascular endothelium, Molecular imaging, Nuclear medicine, Adrenomedullin, Lung perfusion
Background
It is well established that pulmonary perfusion is not
homogeneously distributed [1, 2]. Both gravity-dependent
and gravity-independent factors contribute to the spatial
distribution of pulmonary perfusion, their relative im-
portance being the subject of passionate scientific debates
[3–7]. There is however consensus that this heterogeneity
confers great capacitance to the pulmonary vasculature
and the possibility to increase (recruit) tissue perfusion for
gas and metabolic exchanges in response to increasing
cardiac output. A study of the spatial distribution of pul-
monary perfusion may be of great value in evaluating the
pulmonary vascular reserve and its variations in health
and disease.
Various imaging modalities have been utilized to study
the spatial distribution of pulmonary perfusion in humans
including computerized tomography (CT), magnetic reson-
ance imaging (MRI), positron emission tomography and
single-photon emission computed tomography (SPECT).
All of these methods have relied on the use of physical
and structural agents distributed within the pulmonary
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circulation and whose external signals are reflections of
flow. There is therefore currently no clinically validated
imaging agent that relies on biologic properties of the
endothelium and can quantitatively assess the spatial
distribution of perfusion to the metabolically active
pulmonary circulation and its variations in health and
disease.
We developed a new tracer that can provide molecular
SPECT imaging of the perfused lung capillaries by bind-
ing to the pulmonary vascular endothelium. This tracer
is an adrenomedullin receptor ligand called PulmoBind.
PulmoBind was specifically developed for molecular
SPECT imaging of the pulmonary circulation by label-
ling with 99mTc [8]. Adrenomedullin receptors are abun-
dantly distributed in human alveolar capillaries mostly at
the luminal surface of the vascular endothelium [9–11]
and are responsible for important lung clearance of this
peptide [12]. A safety and dosimetric study of Pulmo-
Bind in human subjects was recently completed [13].
PulmoBind was found to be safe with rapid and import-
ant lung uptake. The majority of injected PulmoBind
(~58 %) is retained by the human lung.
The primary aim of this study was to analyse the
spatial distribution of the perfused lung capillaries in
healthy human subjects by molecular SPECT imaging
using PulmoBind. A secondary aim was to compare this
distribution to that obtained with SPECT PulmoBind
imaging in a quadruped mammal (dogs). Evaluation of
the geometric distribution of lung perfusion could be
useful in the earlier diagnosis of lung vascular disorders
such as pulmonary hypertension. Indeed, subjects suffer-
ing from pulmonary hypertension are diagnosed on aver-
age 2 years after their initial medical contact.
Methods
We studied subjects enrolled into the PulmoBind phase
I safety study (study number: PB-01) conducted at the
Montreal Heart Institute and registered at Clinicaltrials.-
gov (NCT01539889) [13]. Twenty healthy non-smoking
volunteers (18 men, 2 women) with a mean age of 34 ±
15 years (mean ± SD) and weight of 75 ± 14 kg (mean ±
SD) were included into study PB-01. In one male sub-
ject, SPECT imaging was not analysable due to improper
injection of the tracer so that 19 subjects were included
in the present study. They had normal biochemistry and
haematology, echocardiogram, chest X-rays and respiratory
function tests. The study was approved by the institutional
ethic and scientific review boards and was done in accord-
ance with the Declaration of Helsinki and International
Conference on Harmonization/Good Clinical Practice
guidelines. Written informed consent was obtained from
each participant.
Details concerning the synthesis and radiolabelling
of PulmoBind were previously described thoroughly
[8]. The subjects received between 5 and 15 mCi of
99mTc-PulmoBind with a mean radiochemical purity
of 95 ± 4 % (mean ± SD). Prior to administration, total
injection syringe activity was determined. The participants
were lying in supine position 30 min before administra-
tion. 99mTc-PulmoBind was injected intravenously over
3 min with an automatic injector. Ninety minutes later,
SPECT imaging was performed with an E-cam Dual Head
Gamma Camera equipped with a low-energy and
high-resolution collimator. Acquisition parameters were
128 × 128 pixels matrix, 64 frames over 360°, zoom 1.0,
pixels size of 2.67 mm, 35 s per acquisition view and total
imaging time of 20 min. Following the imaging protocol,
residual activity of the syringe was measured to determine
the injected activity.
Image analysis
Tomographic datasets were reconstructed using 3D or-
dered subset expectation maximization (OSEM) iterative
reconstruction algorithm with 3D Gaussian filtering for
noise reduction. Semi-automatic 3D regions of interest
(ROIs) were drawn using ITK-snap 2.2.0 and analysed
using in-house software designed with MATLAB 2013a
((Mathworks, Natick, MA, USA).
To quantify the spatial distribution of pulmonary per-
fusion, voxels within the ROI for each slice following the
dorsoventral, caudocranial and mediolateral axes were
extracted to measure the number of voxels and total ac-
tivity profile along each of those planes. The right and
left lungs were included into one ROI for each axis. For
the mediolateral axis, the right lung was flipped and
translated to align geometrically with the left lung and
included into one ROI.
Spatial distribution of uptake was determined by first
computing the relative concentration for each slice as a
function of cumulative voxels in the three different axes.
Relative Concentration ¼ Mean activity per voxel in slice
Mean activity of all slices in ROI
 100
The difference between each slice relative concentra-
tion and the overall mean ROI activity (100 %) was then
plotted as a function of cumulative voxels along each re-
spective axis and reported as the relative concentration
difference. Consequently, a slice with mean activity per
voxel equal to mean activity of the ROI would have a
difference of 0 %. A positive or negative difference, re-
spectively, represents the mean percent higher or lower
activity for each slice compared to the whole ROI mean
slice activity.
To determine the activity gradient along each axis,
two distinct same-size compartments each containing
50 % of the voxels were created. The mean relative con-
centrations of the two compartments were subtracted to
determine the gradient along each axis. Thus, equal
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activities in both compartments would give a gradient of
0. A positive or negative difference represents the re-
spective percentage of decreasing of increasing gradient
along the studied axis.
Additionally, to have a complementary graphical rep-
resentation of the activity distribution along each axis, a
graph of cumulative activity as a function of cumulative
voxels was created. Quartiles of activity and their corre-
sponding lung volumes at 25 % (VAQ25), 50 % (VAQ50)
and 75 % (VAQ75) were determined as well as the area
under the curve (AUC) of these graphics. Therefore, in
the event where 25, 50 and 75 % of total activity is
reached before or after 25, 50 and 75 % of total voxels or
in the event where AUC is different from 5000 (AUC of
a directly proportional situation between activity and
volume), this would represent a non-uniform distribu-
tion with a perfusion gradient.
Finally, a semi-quantitative analysis was made to deter-
mine the distribution of activity intensity independently
of the spatial distribution. To do so, a frequency histo-
gram of activity intensity per voxel throughout the ROI
was obtained. The voxels were grouped depending on
their intensity in 15 consecutive bins of increasing
6.67 % activity steps from 0 % (no activity) to 100 %
Fig. 1 Dynamic SPECT imaging of pulmonary perfusion with 99mTc-PulmoBind in human. a Dynamic SPECT imaging after forearm vein injection
of 99mTc-PulmoBind in a human subject. b Lung biodistribution of 99mTc-PulmoBind at various times in human subjects (n = 19). c Whole body
planar scintigraphy in a human 30 min after injection (posterior view)
Table 1 Correlation of Peak 99mTc-PulmoBind uptake and of integrated pulmonary activity-time curves with physiological and respiratory
function parameters
Correlation coefficients
Peak uptake Integrated uptake Indexed peak uptake Indexed integrated uptake
Age −0.76*** −0.59* −0.49* −0.48*
Creatinine 0.38 0.49* 0.19 0.45
Weight 0.41 0.50* −0.34 0.42
Height 0.44 0.50* −0.16 0.45
FVC 0.53* 0.61** 0.002 0.35
FEV1 0.60** 0.69*** 0.01 0.39
FEV1/FVC 0.51* 0.55* 0.02 0.28
PEF 0.48* 0.59** −0.24 0.18
Parameters in the two right columns were indexed to body surface area
FC forced vital capacity; FEV1 forced expiratory volume in 1 s; PEF peak expiratory flow
*p < .05, **p < .01, ***p < .001
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(maximum pixel activity in the ROI). A graph represent-
ing the frequency of voxels (equivalent to the percentage
of lung volume) was then plotted as a function of the 15
intensity bins.
Spatial distribution of 99mTc-PulmoBind in a quadruped
mammal
Five adult mongrel dogs weighing 9–13 kg were used in
this study. Study protocol was approved by the animal
research and ethics review board and conducted in ac-
cordance with the regulations and ethical guidelines
from the Canadian Council for the Care of Laboratory
Animals. After administration of 30 mg/kg pentobarbital
sodium, the animals were intubated with an endo-
tracheal tube. Anaesthesia was maintained with 1–3 %
isoflurane. The animals were installed in supine position,
and an IV catheter installed in a posterior paw vein for
PulmoBind administration. The tracer was injected and
a pulmonary SPECT and image analysis were performed
as described above.
Statistics analysis
Values are means and standard error of the mean
(SEM) unless indicated otherwise. Differences from
the PulmoBind-human group were evaluated by two-
tailed t tests. The pulmonary activity-time curve of
99mTc-PulmoBind was integrated from appearance to
peak. Peak activity and the integrated activity were
corrected for body surface area. Both corrected and
uncorrected parameters were correlated with age,
height, weight, plasma creatinine and respiratory function
test parameters using a Pearson correlation matrix.
Analysis was performed using SAS 9.3 and GraphPad
Prism 6 software.
Fig. 2 Pulmonary spatial distribution of 99mTc-PulmoBind in healthy humans (n = 19). a Comparison of the relative concentration difference as a
function of cumulative voxels in dorsoventral, caudocranial and mediolateral axes. b Cumulative relative activity as a function of cumulative voxels the
three planes. c Representative SPECT imaging of spatial distribution in transverse, sagittal and coronal planes in subject 006. The arrows point in the
direction of perfusion gradients
Table 2 Comparison of pulmonary perfusion gradients in humans and dogs
Dorsoventral (%) Caudocranial (%) Mediolateral (%)
PulmoBind-humans 18.1 ± 2.1 25.7 ± 1.6 −7.0 ± 1.0
PulmoBind-dogs 28.6 ± 2.5* 34.1 ± 5.0* −18.1 ± 2.0**
*p < .05, **p < .001 vs. PulmoBind-humans
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Results
As previously reported, labelled PulmoBind was promin-
ently retained by the lungs with a peak uptake of 58 % ±
1 % of the injected dose occurring 5.5 ± 0.2 min follow-
ing injection with an area under the activity-time curve
(AUC) of 9089 ± 344. Kinetic analysis (Fig. 1) reveals
rapid lung uptake with very slow decay of activity that
remains at 44 % ± 1 % after 30 min and 33 % ± 1 % after
60 min. Whole body planar imaging at 60 min demon-
strates persistent lung activity with elimination of the
tracer by the kidneys and the liver as evidenced by urinary
bladder and gallbladder activities. Complete safety and
dosimetric analysis of 99mTc-PulmoBind were previously
reported [13].
In a new correlation analysis, we find that Peak 99mTc-
PulmoBind uptake by the lungs and the area under the
activity-time curves were inversely correlated with age
and positively correlated with respiratory function pa-
rameters (Table 1). In addition, the integrated activity,
but not peak uptake, correlated with body weight and
height and with plasma creatinine. When parameters
were indexed for body surface area, only age remained
weakly inversely correlated with both indices, all other
correlations becoming non-significant. This unique cor-
relation was lost when the only two female subjects,
which were also the oldest subjects, were removed from
the analysis.
Spatial distribution of PulmoBind as a function of
cumulative voxels in the different planes
The PulmoBind relative concentration difference and
cumulative activity in the different planes are shown in
Fig. 2 and Table 2. Overall, there was greater activity in
the dorsal and caudal regions of the lungs compared to
the ventral and cranial regions. There was almost even
distribution in the mediolateral plane, the activity being
slightly higher in the lateral regions. This creates a gradi-
ent of decreasing activity of 18.1 ± 2.1 % between the
dorsal and ventral compartments and of 25.7 ± 1.6 % be-
tween the caudal and cranial compartments. Between
the medial and lateral compartments, there was a mild
positive gradient of 7.0 ± 1.0 %. Interestingly, the use of
PulmoBind in supine dogs resulted in perfusion gradi-
ents similar to those observed in supine humans. The
magnitude of the gradient was, however, greater in the
caudocranial axis, followed by the dorsoventral and
sagittal axis (Fig. 3 and Table 2).
Cumulative PulmoBind concentrations as a function of
cumulative voxels in the different planes
Cumulative quartiles representing 25, 50 and 75 % of
total lung activity and their respective corresponding cu-
mulative % voxels and AUCs are presented in Table 3
and Fig. 4 for the three axes. For PulmoBind in humans,
there is asymmetrical distribution of activity as each ac-
tivity quartile is reached before its respective cumulative
voxels quartile in the dorsoventral and the caudocranial
axis. There was again more even distribution in the
Fig. 3 Comparative distribution of lung perfusion in humans and
dogs. Comparison of the relative concentration difference as a
function of cumulative voxels between PulmoBind-humans (n = 19)
and PulmoBind-dogs (n = 5) in dorsoventral (a), caudocranial (b) and
mediolateral axes (c)
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mediolateral plane, as quartiles of activity were only
slightly higher than corresponding cumulative voxels.
Results for PulmoBind in dogs also showed evident
gradients of a greater magnitude than those in humans.
Frequency histograms of lung activity for PulmoBind
The percentage of lung volume for each of 15 increasing
intensity bins for PulmoBind in humans and dogs are
shown in Fig. 5. The frequency distribution of PulmoBind
intensity in humans and dogs was similar, displaying a
standard bell curve with unimodal distribution slightly
skewed to the left lower intensity bins.
Discussion
The spatial distribution of pulmonary blood flow is
spatially heterogeneous owing to both gravity-dependent
and gravity-independent factors. In human subjects,
physical tracers such as radiolabelled MAA with SPECT
imaging or intravascular contrast agents with computed
tomography or magnetic resonance imaging have been
used to study the distribution of blood flow. The aim of
the current study was to use, for the first time, a meta-
bolic tracer of pulmonary perfusion to determine the
spatial distribution of lung microcirculatory perfusion.
To explore the effects of gravity and species-specific
lung geometry, we compared to the results obtained in a
quadruped mammal (dogs) also in the supine position.
We found that the spatial distribution of PulmoBind was
heterogeneous with a predominant uptake in the more
gravity-dependent dorsal and caudal regions of supine
humans. There was consequently pronounced dorsoven-
tral and caudocranial gradients of perfusion. There was
also a milder mediolateral gradient. In supine dogs, the
distribution of PulmoBind showed similar gradients, but
of greater magnitude. Our findings therefore confirm the
presence of a postural perfusion gradient, in the direction
of gravity, present in both humans and in quadrupeds
lying supine.
PulmoBind is derived from human adrenomedullin and
specifically binds to the adrenomedullin receptor. This
receptor, a heterodimer composed of the calcitonin-like
receptor and the receptor activity modifying protein 2
(CLR-RAMP2), is densely distributed in the alveolar capil-
laries of the human lungs. Accordingly, adrenomedullin is
rapidly extracted upon its first pass through the pulmon-
ary circulation. PulmoBind uptake by the lung is therefore
modified not only by blockage of the large pulmonary
arteries, but can also detect blockage of small pulmonary
arterioles in models of pulmonary arterial hypertension
such as the monocrotaline model [14] and the hypoxia-
sugen model [15]. As such, PulmoBind is a metabolic
tracer and its distribution is related of lung microcircula-
tory perfusion and endothelium integrity. Consequently, a
potential pitfall to the use of PulmoBind for the evaluation
of perfusion would be the lack of uptake due to adreno-
medullin receptor downregulation or desensitization,
rather than reduced perfusion of capillaries. This differs
from MAA which distribution relies exclusively on their
physical properties. Approximately 500,000 MAA particles
varying in size from 10 to 90 μm are intravenously
injected and get trapped into the microcirculation follow-
ing the distribution of pulmonary blood flow, which will
temporarily occlude 1 in 1000 pulmonary arterioles. The
number of particles injected and their size will vary be-
tween tests. Radiolabelled MAA have been used to semi-
quantitatively assess the spatial pulmonary perfusion in
normal lungs [1, 16–19]. Similar to these previous studies,
but using a different methodological approach, we observe
gravity-dependent and gravity-independent distribution of
MAA in humans. Previous investigators have hypothe-
sized that isogravitational heterogeneity resulted from
varying regional vascular conductance at branching points
[2, 20]. Indeed, studies performed in microgravity environ-
ment revealed that some lung perfusion heterogeneity
persisted [21]. A novel fractal model incorporating isogra-
vitational heterogeneity was proposed by Glenny [22–24]
and suggests that as spatial resolution of the instruments
Table 3 Volume of activity quartiles and areas under the cumulative activity curves
Dorsoventral Caudocranial Mediolateral
VAQ25 (%) PulmoBind-humans 20.9 ± 0.4 23.3 ± 0.2 27.8 ± 0.2
PulmoBind-dogs 21.6 ± 0.5 22.1 ± 1.1 28.8 ± 0.5*
VAQ50 (%) PulmoBind-humans 45.2 ± 0.6 44.4 ± 0.3 51.6 ± 0.2
PulmoBind-dogs 43.5 ± 0.6 42.4 ± 1.1* 54.1 ± 0.5**
VAQ75 (%) PulmoBind-humans 72.4 ± 0.4 67.9 ± 0.4 74.2 ± 0.2
PulmoBind-dogs 68.0 ± 0.4*** 66.6 ± 0.9 76.1 ± 0.2**
AUC-5000 (%2) PulmoBind-humans 302 ± 34 395 ± 25 −92.5 ± 15.8
PulmoBind-dogs 452 ± 39* 502 ± 80 −223 ± 21**
Cumulative voxels representing 25 % (VAQ25), 50 % (VAQ50) and 75 % (VAQ75) of cumulative 99mTc-PulmoBind activity for each axis. AUC-5000 represents the
deviation from a line of identity indicative of a positive or negative gradient vs. PulmoBind-humans
*p < .05, **p < .01, ***p < .001 vs. PulmoBind-humans
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of measure is improved, isogravitational perfusion hetero-
geneity is revealed [3]. Interestingly, PulmoBind activity
gradients in dogs studied in the supine position were quite
similar to those in humans but of higher magnitude,
possibly due to anatomical differences in lung geometry
and posture between species. The frequency distribution
of PulmoBind lung activity (Fig. 5) showed a standard bell
curve profile with unimodal distribution both in humans
and in dogs. This suggests normal distribution of the adre-
nomedullin receptor in the pulmonary circulation of both
species.
In a recent phase I study of PulmoBind, qualitative
analysis of lung scans by experienced nuclear specialist
revealed that PulmoBind imaging quality was superior to
that historically obtained with MAA. Mean PulmoBind
uptake by the human lungs showed little variability.
After indexing for body surface area, uptake did not
correlate with respiratory function parameters. The
only significant correlation, although mild, was an inverse
relationship with age. We also cannot exclude a relation-
ship with gender as the only two female participants were
the two older subjects driving this correlation. Future
studies in a larger number of subjects will be necessary to
explore this issue.
We used a novel approach to the evaluation of spatial
distribution of SPECT imaging activity by computing
relative concentrations and cumulative activity as a func-
tion of cumulative voxels in different axes. By using
cumulative voxels, we reduced inter-individual variability
and we show that this correlated well with distance along
the lungs. Inherent limitations to the use of SPECT im-
aging are its lower resolution compared to MRI or CT
and the occurrence of partial volume and edge effects.
Our findings could have clinical applications as the
spatial distribution of lung perfusion is modified in
physiologic and pathologic conditions. Using the multiple
Fig. 4 Cumulative perfusion activity as a function of lung volume in
humans and dogs. Cumulative relative activity as a function of
cumulative voxels in dorsoventral (a), caudocranial (b) and mediolateral
(c) axes for PulmoBind in humans (n= 19) and PulmoBind in dogs (n= 5)
Fig. 5 Frequency distribution of 99mTc-PulmoBind in the human and
canine lungs. Percentage of lung volume as a function of increasing
activity bins in the lungs as obtained for PulmoBind in humans (n = 19)
and PulmoBind in dogs (n = 5). Bins are numbered 1 to 15 at every
6.67 % cut-off level of the maximal pixel radioactivity from 0 %
(no activity) to 100 % (maximum)
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indicator-dilution technique in exercising dogs, we dem-
onstrated that the metabolically active pulmonary vascular
surface-area increased almost linearly with tripling of
blood flow [12]. There is therefore a pulmonary vascular
“reserve” that can accommodate the increase in cardiac
output and expand the surface for gas exchange and meta-
bolic functions. Lung vascular recruitment in response to
increasing blood flow will accordingly modify the spatial
distribution of pulmonary distribution with a reduction in
the gravitational circulation component. Furthermore,
evaluation of the distribution of pulmonary perfusion
could be of value in the evaluation of lung disorders, such
as pulmonary arterial hypertension. A recent study evalu-
ating the distribution of MAA demonstrated that its dis-
tribution was modified in subjects with pulmonary arterial
hypertension [25]. A phase II study of PulmoBind in sub-
jects with pulmonary arterial hypertension will be evaluat-
ing this concept (Clinicaltrials.gov NCT02216279). A
study of the spatial distribution of the metabolically active
pulmonary circulation at rest and with increasing pulmon-
ary blood flow, such as exercise, could provide a unique
insight into the capacity of the lung to recruit vascular
surface area. Conversely, variations in the spatial distri-
bution of pulmonary perfusion in conditions associated
with a loss of recruitable pulmonary perfusion, such as
pulmonary arterial hypertension, could provide a
unique method to diagnose and evaluate lung vascular
dysfunction. It is estimated that more than 50 % of the
pulmonary vascular bed is lost before pulmonary hyper-
tension becomes hemodynamically detectable. Detections
of variations in spatial distribution of flow may provide
earlier detection of the disease process.
Conclusions
We used an adrenomedullin receptor ligand to evaluate
the spatial distribution of the perfused lung microcircu-
lation in the supine human. The perfusion was heteroge-
neous with a predominant distribution in the more
gravity-dependant dorsal and caudal lung regions. A
similar gradient was confirmed in supine dogs. Future
studies are needed to determine if this novel endothelial
cell tracer could be used to detect physiologic and
pathologic variations of lung perfusion in conditions
such as pulmonary hypertension.
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